M. Buchbinder

Journal of the American College of Cardiology · 2009–2017

A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Whom M. Buchbinder trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. John K. Kruschke

Papers from M. Buchbinder's perspective

Ordered by how strongly the researchers M. Buchbinder trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation (Annals of Internal Medicine)
  2. Bayesian data analysis.
  3. The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation (Annals of Internal Medicine)
  4. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. (European Heart Journal)
  5. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. (Journal of the American Medical Association (JAMA))
  6. Why do patients with atrial fibrillation not receive warfarin? (Archives of Internal Medicine)
  7. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.
  8. Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. (Journal of the American College of Cardiology)
  9. The logistic EuroSCORE
  10. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. (The Lancet)

Their papers